Literature DB >> 8601857

Outcome of severe brain injury: a multimodality neurophysiologic study.

A D Rae-Grant1, N Eckert, P J Barbour, J E Castaldo, W Gee, C J Wohlberg, Z S Lin, J F Reed.   

Abstract

We screened all head-injured trauma patients admitted to Lehigh Valley Hospital during a 2-year period. From 725 screened patients, 69 patients in a coma on the second day after trauma were entered into this study. During the first week, these patients underwent electroencephalography (EEG), evoked potentials, ocular pneumoplethysmography, and transcranial Doppler (TCD) sonography. Clinical examinations were undertaken 2 and 7 days after trauma. Test results were correlated with functional clinical outcome at 6 months. In a multiple regression analysis, EEG was the major independent variable that significantly predicted 6-month outcome based on Glasgow Outcome Scale score. Transcranial Doppler sonography contributed a small additional component. Though EEG was the most significant predictive factor in this neurophysiological battery, it did not add significantly to the predictive power of Glasgow Coma Scale score determined at day 7. These findings suggest that in neurophysiologic testing in this type of patient is not useful in improving predictive outcome data.

Entities:  

Mesh:

Year:  1996        PMID: 8601857

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  2 in total

1.  Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring.

Authors:  P M Vespa; M R Nuwer; V Nenov; E Ronne-Engstrom; D A Hovda; M Bergsneider; D F Kelly; N A Martin; D P Becker
Journal:  J Neurosurg       Date:  1999-11       Impact factor: 5.115

Review 2.  Resting-State Electroencephalography for Prognosis in Disorders of Consciousness Following Traumatic Brain Injury.

Authors:  Ruth Pauli; Alice O'Donnell; Damian Cruse
Journal:  Front Neurol       Date:  2020-12-04       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.